Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| astrocyte | 16 studies | 48% ± 22% | |
| oligodendrocyte | 15 studies | 66% ± 17% | |
| oligodendrocyte precursor cell | 14 studies | 66% ± 20% | |
| GABAergic neuron | 11 studies | 57% ± 27% | |
| glutamatergic neuron | 11 studies | 59% ± 25% | |
| interneuron | 6 studies | 64% ± 22% | |
| pericyte | 6 studies | 37% ± 14% | |
| neuron | 5 studies | 39% ± 15% | |
| endothelial cell | 5 studies | 40% ± 18% | |
| microglial cell | 4 studies | 41% ± 19% | |
| differentiation-committed oligodendrocyte precursor | 3 studies | 70% ± 8% | |
| GABAergic interneuron | 3 studies | 65% ± 4% | |
| retinal ganglion cell | 3 studies | 36% ± 18% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 17 studies | 51% ± 23% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 100% | 1885.08 | 2636 / 2642 | 98% | 25.19 | 694 / 705 |
| thymus | 100% | 1607.99 | 652 / 653 | 84% | 15.52 | 508 / 605 |
| adrenal gland | 72% | 274.01 | 186 / 258 | 79% | 17.97 | 181 / 230 |
| breast | 94% | 611.28 | 430 / 459 | 25% | 0.79 | 283 / 1118 |
| uterus | 99% | 778.90 | 168 / 170 | 9% | 0.62 | 43 / 459 |
| ureter | 0% | 0 | 0 / 0 | 100% | 9.06 | 1 / 1 |
| adipose | 91% | 441.80 | 1093 / 1204 | 0% | 0 | 0 / 0 |
| lung | 79% | 280.91 | 454 / 578 | 8% | 0.33 | 96 / 1155 |
| eye | 0% | 0 | 0 / 0 | 76% | 12.05 | 61 / 80 |
| prostate | 62% | 236.51 | 152 / 245 | 13% | 0.39 | 64 / 502 |
| ovary | 58% | 221.81 | 105 / 180 | 16% | 0.72 | 69 / 430 |
| skin | 57% | 191.88 | 1025 / 1809 | 11% | 0.53 | 54 / 472 |
| blood vessel | 60% | 219.06 | 802 / 1335 | 0% | 0 | 0 / 0 |
| intestine | 52% | 162.09 | 504 / 966 | 8% | 0.35 | 41 / 527 |
| pancreas | 9% | 20.52 | 28 / 328 | 51% | 1.82 | 91 / 178 |
| stomach | 35% | 203.86 | 124 / 359 | 11% | 0.52 | 31 / 286 |
| liver | 8% | 26.04 | 19 / 226 | 29% | 2.86 | 119 / 406 |
| kidney | 15% | 39.83 | 13 / 89 | 20% | 1.08 | 179 / 901 |
| esophagus | 23% | 62.31 | 333 / 1445 | 7% | 0.26 | 12 / 183 |
| bladder | 10% | 17.19 | 2 / 21 | 4% | 0.16 | 19 / 504 |
| heart | 11% | 27.99 | 99 / 861 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 7% | 0.24 | 2 / 29 |
| tonsil | 0% | 0 | 0 / 0 | 7% | 0.22 | 3 / 45 |
| muscle | 7% | 16.67 | 53 / 803 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
| GO_0060078 | Biological process | regulation of postsynaptic membrane potential |
| GO_0034220 | Biological process | monoatomic ion transmembrane transport |
| GO_0050804 | Biological process | modulation of chemical synaptic transmission |
| GO_0035176 | Biological process | social behavior |
| GO_0007215 | Biological process | glutamate receptor signaling pathway |
| GO_0035249 | Biological process | synaptic transmission, glutamatergic |
| GO_0099175 | Biological process | regulation of postsynapse organization |
| GO_0098978 | Cellular component | glutamatergic synapse |
| GO_0098982 | Cellular component | GABA-ergic synapse |
| GO_0098839 | Cellular component | postsynaptic density membrane |
| GO_0070062 | Cellular component | extracellular exosome |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0008066 | Molecular function | glutamate receptor activity |
| GO_0042802 | Molecular function | identical protein binding |
| GO_1904315 | Molecular function | transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential |
| Gene name | GRID1 |
| Protein name | Glutamate receptor Glutamate receptor ionotropic, delta-1 (GluD1) (GluR delta-1 subunit) |
| Synonyms | KIAA1220 hCG_1818441 |
| Description | FUNCTION: Receptor for glutamate. L-glutamate acts as an excitatory neurotransmitter at many synapses in the central nervous system. The postsynaptic actions of Glu are mediated by a variety of receptors that are named according to their selective agonists. FUNCTION: Receptor for glutamate that functions as a ligand-gated ion channel in the central nervous system and plays an important role in excitatory synaptic transmission. L-glutamate acts as an excitatory neurotransmitter at many synapses in the central nervous system. . FUNCTION: Receptor for glutamate that functions as a ligand-gated ion channel in the central nervous system and plays an important role in excitatory synaptic transmission. L-glutamate acts as an excitatory neurotransmitter at many synapses in the central nervous system. . |
| Accessions | A0A8D9UJ36 ENST00000327946.12 [Q9ULK0-1] Q9ULK0 ENST00000464741.2 G3V186 |